Ramin Ebrahimi

1 month ago | onlinelibrary.wiley.com | Fahim Ebrahimi |Ramin Ebrahimi |Jan Hendrik Niess |Ali Mahdi

1 Introduction Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are chronic immune-mediated inflammatory conditions that affect the gastrointestinal tract [1, 2]. A relapsing–remitting course, variable disease severity and differing responses to treatment characterise them. The disease significantly impacts patients' health-related quality of life and work productivity [3].